The director of the University of Rochester Alzheimer's Disease Care, Research and Education Program spoke about the need to rethink trial design and Alzheimer neuropsychiatric symptom management.
Anton Poteinsson, MD
Advertisement
Articles by Anton Poteinsson, MD
Advertisement
Latest Updated Articles
Anton P. Porsteinsson, MD: Addressing Trial Design and Symptom Intervention in Alzheimer DiseasePublished: August 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
How Multiple Sclerosis Affects Men
2
ECTRIMS Congress 2025: Top Expert Interviews and Key Takeaways
3
NeurologyLive® Brain Games: October 12, 2025
4
36-Month Data on Bemdaneprocel, Ravulizimab Shines in CHAMPION-NMOSD Trial, FDA Fast Tracks Anti-MBTR Tau Antibody
5
